{"id":"W2883590012","doi":"10.1136/annrheumdis-2018-eular.5825","title":"AB0912 Two-year efficacy and safety of guselkumab for treatment of moderate-to-severe psoriasis: phase 3 voyage 1 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Clinical trial; Phase (matter); Dermatology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001951054,0.0001413582,0.0006017573,0.00003700206,0.00009362223,0.000007625099,0.0001016955,0.0000261934,0.0001216058],"category_scores_gemma":[0.001016943,0.00008237633,0.0002047385,0.0001105211,0.0001867076,0.00006355451,0.00005479993,0.00002051886,0.00000302557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001053576,"about_ca_system_score_gemma":0.00006536003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005797809,"about_ca_topic_score_gemma":0.000003859975,"domain_scores_codex":[0.9988922,0.00008103372,0.0004684225,0.0001564867,0.0002244906,0.0001773729],"domain_scores_gemma":[0.9982195,0.0008260994,0.0002846417,0.0003000465,0.0002096018,0.000160123],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6851844,0.0125265,0.0005578321,0.001775494,0.004142072,0.00000189132,0.00262695,0.00005630669,0.0005121407,0.001591151,0.008735942,0.2822893],"study_design_scores_gemma":[0.7852243,0.0544801,0.01858984,0.004590616,0.01046493,0.00001404774,0.002604034,0.00390145,0.07785156,0.006421005,0.03499668,0.0008614338],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922402,0.002133072,0.00004982215,0.002607679,0.0001579373,0.001690372,0.0003872289,0.00001062113,0.0007230712],"genre_scores_gemma":[0.997468,0.001841447,0.0002027485,0.0001888618,0.0001061499,0.00004808104,0.000006849414,0.00001240972,0.0001254867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2814279,"threshold_uncertainty_score":0.3359209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1387671470862311,"score_gpt":0.4467224896793756,"score_spread":0.3079553425931446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}